Therapeutic Cancer Vaccines

Expanded phase I combination trial of GVAX immunotherapy for prostate cancer and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHPRC)

(2017) W. Gerritsen et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine

(2010) Benedetto Farsaci et al.   INTERNATIONAL JOURNAL OF CANCER

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   JOURNAL OF CLINICAL ONCOLOGY

DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer

(2010) Jordan T. Becker et al.   JOURNAL OF IMMUNOTHERAPY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression

(2010) R. A. Madan et al.   ONCOLOGIST

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy

(2009) Vittore Cereda et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

(2009) James L. Gulley et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy

(2009) Preeta Tyagi et al.   Clinical Lung Cancer

A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer

(2009) Mayer Fishman   EXPERT OPINION ON BIOLOGICAL THERAPY

Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer

(2009) Ravi A Madan et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses

(2009) Coral-Ann M. Almeida et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Vaccines for the Treatment of Non-Small Cell Lung Cancer: A Renewed Anticancer Strategy

(2009) C. Gridelli et al.   ONCOLOGIST

Prognostic factors in low-grade non-Hodgkin lymphomas

(2009) Massimo Federico et al.   Current Hematologic Malignancy Reports

CD54 is a surrogate marker of antigen presenting cell activation

(2008) N. A. Sheikh et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant

(2008) R. J. Lechleider et al.   CLINICAL CANCER RESEARCH

Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies

(2008) Malka Epel et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

BLP-25 liposomal vaccine: a promising potential therapy in nonsmall-cell lung cancer

(2008) Erin Powell et al.   Expert Review of Respiratory Medicine